From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

Low-Dose Doxycycline for Moderate Acne

This regimen may be the safest approach to antibiotic treatment of acne.

The usual dosage of oral doxycycline for treating acne is 50 mg to 100 mg twice daily. This agent presumably works by decreasing the population of the skin bacterium Propionibacterium acnes, which is thought to be an important element in the pathogenesis of acne. Previous research has suggested other potential actions of doxycycline, including down-regulation of inflammatory mediators and inhibition of P. acnes-derived lipase, with a resultant reduction in levels of follicular-free fatty acids. These effects may occur at doses of doxycycline that are too low to inhibit bacterial growth. In this manufacturer-sponsored, multicenter, double-blind study, investigators examined the effect on moderate facial acne of a 6-month course of 20-mg doxycycline twice daily compared with placebo.

Among the 40 patients who completed the study, the mean reduction in inflammatory lesions and comedones was 52% in the doxycycline group versus 18% in the placebo group, a significant difference. There were no changes in either group in the composition of the surface skin flora or in antimicrobial susceptibility.

Comment: Whether doxycycline improved acne in these patients by an antimicrobial effect on organisms in the follicles or by another action is unclear, but this low-dose regimen appears to treat acne effectively without altering the antimicrobial susceptibility of the skin flora. Furthermore, previous trials of low-dose doxycycline have demonstrated no change in the antibiotic sensitivity of bacteria in the gastrointestinal and genitourinary tracts. This therapy may be the safest approach to using antibiotics for treating acne (see also JW Dermatology May 14 2003, and Arch Dermatol 2003; 139:467).

— Jan V. Hirschmann, MD

Published in Journal Watch Dermatology May 28, 2003

Citation(s):

Skidmore R et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003 Apr; 139:459-64.

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2003. Massachusetts Medical Society. All rights reserved.